Red Cell Partners - aVenture Asset Manager Research
Location
Washington, D.C., DC, US
Founded
2020
Red Cell Partners is a venture capital firm focused on incubating and investing in technology-led companies addressing critical challenges in healthcare and national security. The firm targets rapidly-scalable solutions that bring revolutionary advancements to market. Red Cell Partners typically invests across various stages, from pre-seed to later rounds, with investments ranging from $3 million to $200 million.
Notable portfolio companies include Epirus, a directed energy systems company, and Paravision, an AI-powered computer vision platform. Red Cell Partners offers value-add services through its incubation model, leveraging deep industry expertise to develop powerful tools and solutions. The firm's leadership includes partners with backgrounds in technology, healthcare, and national security, positioning them to provide strategic guidance to portfolio companies in these sectors.
Red Cell Partners - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies6
Current Portfolio Count6
Top Investment Stages
Pre-Seed2 (33.3%)
Series A2 (33.3%)
Series B1 (16.7%)
Series C1 (16.7%)
Stage Mix
Pre-Seed 33%Series A 33%Series B 17%Series C 17%
Concentration shown as share of disclosed investments by stage.
